Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2120352rdf:typepubmed:Citationlld:pubmed
pubmed-article:2120352lifeskim:mentionsumls-concept:C0440744lld:lifeskim
pubmed-article:2120352lifeskim:mentionsumls-concept:C1537647lld:lifeskim
pubmed-article:2120352lifeskim:mentionsumls-concept:C0025723lld:lifeskim
pubmed-article:2120352lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:2120352lifeskim:mentionsumls-concept:C0019763lld:lifeskim
pubmed-article:2120352pubmed:issue1-2lld:pubmed
pubmed-article:2120352pubmed:dateCreated1990-11-9lld:pubmed
pubmed-article:2120352pubmed:abstractTextThe CCGG and GCGC sites of the human HLA-DR alpha gene are hypermethylated in human tissues (including B-lymphocytes, T-lymphocytes, muscle, brain, sperm, skin, kidney, suprarenal and mammary glands) and three B-lymphoid cell lines. Therefore, the HLA-DR alpha gene can be transcribed even though extensively methylated. The only exception to the hypermethylated state of the HLA-DR alpha gene is represented by one or both of the two HhaI sites (H1 and H2) localized in the 5' portion of the gene. Analysis of the computer-generated secondary structure of the HLA-DR alpha mRNA suggests that the H1 and H2 sites belong to a region (5'-GAGCGCCCA-3'/5'-UGAGCGCUC-3') exhibiting extensive base pairing. Therefore, unmethylation of these CG sites can contribute in preventing mCG----TG/CA changes in this region, which would lead to extensive alterations of the secondary structure of the 5' portion of the HLA-DR alpha MRNA. On the other hand, the selective pressure to maintain unaltered the methylated CG dinucleotides in the coding regions of the HLA-DR alpha gene could be due to codon restrictions, since the majority of the methylation-related CG----TG or CG----CA variations would generate aminoacid changes. Accordingly, the analysis of different HLA-DR alpha genomic sequences indicates that variations of the CpG dinucleotides occur only in the non-coding portions of the HLA-DR alpha gene.lld:pubmed
pubmed-article:2120352pubmed:languageenglld:pubmed
pubmed-article:2120352pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2120352pubmed:citationSubsetIMlld:pubmed
pubmed-article:2120352pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2120352pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2120352pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2120352pubmed:statusMEDLINElld:pubmed
pubmed-article:2120352pubmed:issn0305-1811lld:pubmed
pubmed-article:2120352pubmed:authorpubmed-author:VillaMMlld:pubmed
pubmed-article:2120352pubmed:authorpubmed-author:NataliP GPGlld:pubmed
pubmed-article:2120352pubmed:authorpubmed-author:PivaRRlld:pubmed
pubmed-article:2120352pubmed:authorpubmed-author:GambariRRlld:pubmed
pubmed-article:2120352pubmed:authorpubmed-author:BarbieriRRlld:pubmed
pubmed-article:2120352pubmed:authorpubmed-author:GiacominiPPlld:pubmed
pubmed-article:2120352pubmed:authorpubmed-author:VoliniaSSlld:pubmed
pubmed-article:2120352pubmed:authorpubmed-author:NastruzziCClld:pubmed
pubmed-article:2120352pubmed:issnTypePrintlld:pubmed
pubmed-article:2120352pubmed:volume17lld:pubmed
pubmed-article:2120352pubmed:ownerNLMlld:pubmed
pubmed-article:2120352pubmed:authorsCompleteYlld:pubmed
pubmed-article:2120352pubmed:pagination51-66lld:pubmed
pubmed-article:2120352pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:meshHeadingpubmed-meshheading:2120352-...lld:pubmed
pubmed-article:2120352pubmed:articleTitleMethylation pattern of the HLA-DR alpha gene in human tissues.lld:pubmed
pubmed-article:2120352pubmed:affiliationIstituto di Chimica Biologica, Ferrara, Italy.lld:pubmed
pubmed-article:2120352pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2120352pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed